now recommend this specific procedure for any candidate with farsightedness with or without astigmatism and those with hyperopia.
With recent FDA approval, CustomVue LASIK ahs become the only wavefront guided laser corrective eye surgery approved for treating hyperopia in the United States.
"VISX's new CustomVue Hyperopia procedure is a significant step forward in the treatment of farsightedness. The overall quality of vision with this new procedure is so superior that I plan to treat all of my qualified patients with CustomVue Hyperopia", says Colman Fraff, M.D. and principal VISX investigator for multi-center clinical studies.
In a limited number of cases the CustomVue LASIK procedure may cause a loss of BSCVA or best spectacle corrected visual acuity. What this means is that a person who can be corrected to 20/20 vision with eyeglasses may have slightly less clear vision after CustomVue LASIK surgery that will not be treatable with corrective lenses.
For more detailed information about various types of corrective eye surgery, visit an informational website such as Eye Topics (http://www.eyetopics.com/).
Laser Eye Surgery
Many times the terms “refractive surgery” and “laser eye surgery” are commonly used interchangeable though this is not accurate, as lasers are often used to treat nonrefractive vision Read more...
|
Let's Take a Closer Look at Laser Eye Surgery
By Morgan Hamilton
Our vision is probably the most utilized sensory faculty that we have. For most people the ability to see clearly is absolutely vital. Unfortunately, our eyes frequently suffer from diseases, abuse, Read more...
|
Laser Eye Surgery
Many times the terms “refractive surgery” and “laser eye surgery” are commonly used interchangeable though this is not accurate, as lasers are often used to treat nonrefractive vision Read more...
|
CustomVue LASIK
Customvue LASIK is one of the few types of laser eye surgery procedures that is specifically well suited for farsightedness, farsightedness with astigmatism and hyperopia without astigmatism. Read more...
|
